Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Macrogenics (MGNX) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for Macrogenics (MGNX) over the last 14 years, with Q3 2025 value amounting to -$30.6 million.

  • Macrogenics' Free Cash Flow fell 15138.83% to -$30.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$164.8 million, marking a year-over-year decrease of 16699.18%. This contributed to the annual value of -$72.1 million for FY2024, which is 986.63% up from last year.
  • According to the latest figures from Q3 2025, Macrogenics' Free Cash Flow is -$30.6 million, which was down 15138.83% from -$47.7 million recorded in Q2 2025.
  • Macrogenics' Free Cash Flow's 5-year high stood at $59.6 million during Q3 2024, with a 5-year trough of -$59.1 million in Q1 2022.
  • Over the past 5 years, Macrogenics' median Free Cash Flow value was -$35.7 million (recorded in 2023), while the average stood at -$27.3 million.
  • The largest annual percentage gain for Macrogenics' Free Cash Flow in the last 5 years was 26665.27% (2024), contrasted with its biggest fall of 181663.16% (2024).
  • Over the past 5 years, Macrogenics' Free Cash Flow (Quarter) stood at -$55.7 million in 2021, then surged by 151.95% to $28.9 million in 2022, then crashed by 199.07% to -$28.7 million in 2023, then tumbled by 36.19% to -$39.0 million in 2024, then grew by 21.56% to -$30.6 million in 2025.
  • Its Free Cash Flow stands at -$30.6 million for Q3 2025, versus -$47.7 million for Q2 2025 and -$47.4 million for Q1 2025.